Compare Agilent Technologies Inc (A) vs Rex Fang & Innovation Equity Premium Income ETF (FEPI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs Rex Fang & Innovation Equity Premium Income ETF — how do they compare? Agilent Technologies Inc trades at $128.99 (market cap $37.04B), while Rex Fang & Innovation Equity Premium Income ETF trades at $41.77. The key difference: Agilent Technologies Inc pays a 0.78% dividend while Rex Fang & Innovation Equity Premium Income ETF pays none. Which is the better fit depends on your goals.
| A | FEPI | |
|---|---|---|
Market Cap | $37.04B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $157.20 | $49.54 |
52-Week Low | $110.24 | $38.13 |
Enterprise Value | $38.59B | — |
Dividend Yield | 0.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
FEPI (REX FANG & Innovation Equity Premium Income ETF) trades at $42.53, up 1.5% with a bearish technical signal. The ETF employs a covered call strategy on concentrated tech holdings, generating high weekly dividends but facing NAV erosion concerns. Recent transition to weekly distributions aims to enhance income appeal, though technical indicators show selling pressure outweighing buying signals.
The outlook balances high yield appeal against structural limitations. The 25% dividend yield attracts income seekers, but the covered call strategy caps upside potential during tech rallies. Key risks include concentrated exposure to volatile AI/mega-cap stocks and persistent NAV erosion, requiring careful risk-reward assessment for long-term holders.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Rex Fang & Innovation Equity Premium Income ETF
FEPI provides exposure to top innovation stocks while generating monthly income. It uses a covered call strategy on high-volatility tech stocks to capture option premiums for investors.
Read more on FEPI →
